ES2114184T3 - Composicion a base de microparticulas en fase condensada y procedimiento. - Google Patents
Composicion a base de microparticulas en fase condensada y procedimiento.Info
- Publication number
- ES2114184T3 ES2114184T3 ES94909762T ES94909762T ES2114184T3 ES 2114184 T3 ES2114184 T3 ES 2114184T3 ES 94909762 T ES94909762 T ES 94909762T ES 94909762 T ES94909762 T ES 94909762T ES 2114184 T3 ES2114184 T3 ES 2114184T3
- Authority
- ES
- Spain
- Prior art keywords
- procedure
- composition based
- condensed phase
- phase microparticles
- microparticles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5176—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1664—Compounds of unknown constitution, e.g. material from plants or animals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
- G01N33/586—Liposomes, microcapsules or cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Dispersion Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
Abstract
SE PRESENTAN UNA COMPOSICION DE MICROPARTICULAS ENCAPSULADAS Y SU METODO DE USO EN APLICACIONES DE ADMINISTRACION DE FARMACOS Y DE DIAGNOSTICO. TAMBIEN SE PRESENTAN LOS METODOS PARA CONSERVAR Y ADMINISTRAR COMPUESTOS DE FARMACOS A UN ALTO NIVEL DE CONCENTRACION EN MICROPARTICULAS DE FASE CONDENSADA.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1768193A | 1993-02-12 | 1993-02-12 | |
PCT/US1994/001924 WO1994017786A1 (en) | 1993-02-12 | 1994-02-10 | Condensed-phase microparticle composition and method |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2114184T3 true ES2114184T3 (es) | 1998-05-16 |
Family
ID=21783984
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94909762T Expired - Lifetime ES2114184T3 (es) | 1993-02-12 | 1994-02-10 | Composicion a base de microparticulas en fase condensada y procedimiento. |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0684812B1 (es) |
JP (1) | JPH08509956A (es) |
AT (1) | ATE162397T1 (es) |
AU (1) | AU676543B2 (es) |
CA (1) | CA2155648C (es) |
DE (1) | DE69408122T2 (es) |
DK (1) | DK0684812T3 (es) |
ES (1) | ES2114184T3 (es) |
WO (1) | WO1994017786A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9320668D0 (en) | 1993-10-07 | 1993-11-24 | Secr Defence | Liposomes containing particulare materials |
CA2193954A1 (en) * | 1994-06-27 | 1996-01-04 | Vu L. Truong | Targeted gene delivery system |
JP2000514440A (ja) * | 1996-07-09 | 2000-10-31 | ザ ジョーンズ ホプキンス ユニバーシティー | 遺伝子輸送システム |
ATE413415T1 (de) | 1996-09-19 | 2008-11-15 | Univ Michigan | Polymere enthaltend polysaccharide wie alginate oder modifizierte alginate |
ATE430199T1 (de) | 1998-01-31 | 2009-05-15 | Univ Arkansas | Verfahren und reagenzien zur verminderung der klinischen reaktion zur allergie |
US7879977B2 (en) | 1998-01-31 | 2011-02-01 | University Of Arkansas | Methods and reagents for decreasing clinical reaction to allergy |
US5952232A (en) * | 1998-09-17 | 1999-09-14 | Rothman; James Edward | Expandible microparticle intracellular delivery system |
DE19943429A1 (de) * | 1999-09-08 | 2001-03-15 | Beiersdorf Ag | Kosmetische und dermatologische Zubereitungen mit einem Gehalt an sulfonierten Kammpolymeren |
JP2004527450A (ja) | 2000-04-06 | 2004-09-09 | シーア ファーマスーティカルズ エルエルシー | 微生物送達システム |
US8246945B2 (en) | 2000-04-06 | 2012-08-21 | University Of Arkansas | Methods and reagents for decreasing clinical reaction to allergy |
US7056535B2 (en) | 2001-12-20 | 2006-06-06 | Kimberly-Clark Worldwide, Inc. | Triggered release from proteinoid microspheres |
US20030138975A1 (en) * | 2001-12-20 | 2003-07-24 | Kimberly-Clark Worldwide, Inc. | Diagnostic signal amplification with proteinoid microspheres |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI84874C (fi) * | 1989-11-02 | 1992-02-10 | Valio Meijerien | Foerfarande foer inkapsling av biologiskt aktiva aemnen, enligt metoden framstaelld kapsel, dess anvaendning och foder innehaollande den. |
US5149543A (en) * | 1990-10-05 | 1992-09-22 | Massachusetts Institute Of Technology | Ionically cross-linked polymeric microcapsules |
FR2677249B1 (fr) * | 1991-06-04 | 1995-03-17 | Biovecteurs As | Vecteur particulaire biodegradable et procede de synthese. |
-
1994
- 1994-02-10 AT AT94909762T patent/ATE162397T1/de not_active IP Right Cessation
- 1994-02-10 JP JP6518397A patent/JPH08509956A/ja active Pending
- 1994-02-10 WO PCT/US1994/001924 patent/WO1994017786A1/en active IP Right Grant
- 1994-02-10 CA CA002155648A patent/CA2155648C/en not_active Expired - Fee Related
- 1994-02-10 ES ES94909762T patent/ES2114184T3/es not_active Expired - Lifetime
- 1994-02-10 AU AU62479/94A patent/AU676543B2/en not_active Ceased
- 1994-02-10 DK DK94909762T patent/DK0684812T3/da active
- 1994-02-10 DE DE69408122T patent/DE69408122T2/de not_active Expired - Fee Related
- 1994-02-10 EP EP94909762A patent/EP0684812B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU6247994A (en) | 1994-08-29 |
DE69408122T2 (de) | 1998-09-03 |
AU676543B2 (en) | 1997-03-13 |
JPH08509956A (ja) | 1996-10-22 |
EP0684812B1 (en) | 1998-01-21 |
CA2155648C (en) | 1999-05-11 |
ATE162397T1 (de) | 1998-02-15 |
EP0684812A1 (en) | 1995-12-06 |
CA2155648A1 (en) | 1994-08-18 |
DE69408122D1 (de) | 1998-02-26 |
DK0684812T3 (da) | 1998-09-21 |
WO1994017786A1 (en) | 1994-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2114184T3 (es) | Composicion a base de microparticulas en fase condensada y procedimiento. | |
WO1994027589A3 (en) | Antidepressant dosage form | |
IT8819693A0 (it) | Apparecchio atto ad operare, in modo pressoche' istantaneo, la distruzione completa dell'ago di siringhe per iniezione, subito dopo il loro impiego. | |
DE69326063D1 (de) | Pharmazeutische und andere darreichungsformen | |
ATE204467T1 (de) | Orale darreichungsform | |
ATE493998T1 (de) | Pharmazeutische zusammensetzung mit einem exendin-4-peptid | |
AU7405387A (en) | Pharmaceutical compositions containing levodopa methyl ester, preparation and therapeutic applications thereof | |
NZ320237A (en) | Stable pharmaceutical forms of administration containing parathormone | |
ATE292453T1 (de) | Antivirale arznei | |
ATE311904T1 (de) | Halbfester verabreichungsträger und arzneimittel | |
ATE282406T1 (de) | Arzneimittel und verfahren zur behandlung von intrazellulären infektionen | |
DE69427485T2 (de) | Verbindungen, zubereitungen und behandlung von allergien und entzündungen | |
FR2768341B1 (fr) | Composition pharmaceutique placebo lyophilisable destinee a imiter un medicament, notamment a base de proteines ou de polypeptides | |
BG105570A (en) | Pharmaceutical compositions for modified release insulin sensitiser | |
ATE221391T1 (de) | Konjugat enthaltend dtpa und albumin zur individuellen dosierung von arzneimitteln | |
SE8800080L (sv) | Laekemedelskomposition | |
EP0683668A4 (en) | PREPARATIONS AND METHODS FOR TRANSDERMAL DRUG ADMINISTRATION. | |
EE03205B1 (et) | Ropivakaiini kasutamine valuvaigistina kasutatava ravimpreparaadi valmistamiseks | |
AR019331A2 (es) | Composicion farmaceutica que contiene un sensibilizador a insulina y un secretagogo de insulina. | |
HK1029277A1 (en) | Pharmaceutical coating composition and method of use. | |
NO302360B1 (no) | NG-monometyl-L-argininhydrokloridderivater | |
SE9904132D0 (sv) | Pharmaceutical composition for treatment of diarrhea | |
TH19526A (th) | วิธีการและสารผสมสำหรับรักษาโรคตับอักเสบชนิดออโตอิมมูน | |
BG49070A1 (en) | Medicinal form for paradontoses treatment | |
GEP20022646B (en) | Use Of Microparticles Having A Protein And An Antibody Adsorbed Thereon For Preparing A Pharmaceutical Composition For Intranasal Administration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 684812 Country of ref document: ES |